{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:05:41Z","timestamp":1784030741730,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":6128,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jpain.2006.05.005","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T13:08:21Z","timestamp":1165496901000},"page":"937-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain"],"prefix":"10.1016","volume":"7","author":[{"given":"Lynn R.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren V.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay H.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2006.05.005_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2006.05.005_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3959(01)00425-0","article-title":"The combination of low dose naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period","volume":"96","author":"Cepeda","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pain.2003.09.011","article-title":"Addition of ultralow dose naloxone to postoperative morphine PCA: Unchanged analgesia and opioid requirement but decreased incidence of opioid side effects","volume":"107","author":"Cepeda","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jpain.2005.01.356","article-title":"Adding ultra-low-dose naltrexone to oxycodone enhances and prolongs analgesia","volume":"6","author":"Chindalore","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib5","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.92.23.10540","article-title":"Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance\/dependence during chronic cotreatment","volume":"92","author":"Crain","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2006.05.005_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3959(99)00223-7","article-title":"Antagonists of excitatory opioid receptor functions enhance morphine\u2019s analgesic potency and attenuate opioid tolerance\/dependence liability","volume":"84","author":"Crain","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0885-3924(03)00139-8","article-title":"Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone","volume":"25","author":"Cruciani","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2006.05.005_bib8","series-title":"Pharmacokinetic study supports bid oral administration of oxytrex in a chronic model of pain","author":"de Kater","year":"2004"},{"key":"10.1016\/j.jpain.2006.05.005_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM200102013440508","article-title":"Low Back Pain","volume":"344","author":"Deyo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2006.05.005_bib10","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1097\/00007632-200011150-00017","article-title":"The Oswestry Disability Index","volume":"25","author":"Fairbank","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.jpain.2006.05.005_bib11","first-page":"75","article-title":"Opioid insights: Opioid-induced hyperalgesia and opioid rotation","volume":"18","author":"Fine","year":"2004","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpain.2006.05.005_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2006.05.005_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0149-2918(01)80093-X","article-title":"Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials","volume":"23","author":"Gandhi","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpain.2006.05.005_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a Short Opiate Withdrawal Scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict Behav"},{"key":"10.1016\/j.jpain.2006.05.005_bib15","series-title":"Selective antagonism of excitatory opioid receptor systems: A pilot clinical study demonstrating enhancement of morphine analgesia by low-dose naloxone in female patients undergoing elective laparotomy","author":"Hamman","year":"2004"},{"key":"10.1016\/j.jpain.2006.05.005_bib16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2006.05.005_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00000542-199904000-00013","article-title":"Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia","volume":"90","author":"Joshi","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2006.05.005_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: Hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jpain.2006.05.005_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0149-7634(89)80022-3","article-title":"Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence","volume":"13","author":"Koob","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jpain.2006.05.005_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pbb.2005.08.008","article-title":"Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats","volume":"82","author":"Leri","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jpain.2006.05.005_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.05.013","article-title":"Chronic very low dose naltrexone attenuates opioid withdrawal expression","volume":"56","author":"Mannelli","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpain.2006.05.005_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00213-005-0022-7","article-title":"Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats","volume":"181","author":"Olmstead","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpain.2006.05.005_bib23","article-title":"The effects of spinal ultra-low doses of an opioid receptor antagonist on systemic morphine dependence","author":"Oxbro","year":"2003","journal-title":"Soc Neurosci"},{"key":"10.1016\/j.jpain.2006.05.005_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2006.05.005_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(97)00197-2","article-title":"Ultra-low doses of naltrexone or etorphine increase morphine\u2019s antinociceptive potency and attenuate tolerance\/dependence in mice","volume":"757","author":"Shen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2006.05.005_bib26","first-page":"50","article-title":"PTI-555, reverses and prevents morphine-induced tolerance and naloxone-precipitated withdrawal in mice chronically treated with morphine","volume":"3","author":"Shen","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib27","first-page":"49","article-title":"PTI-801, a novel formulation of oxycodone, shows absence of tolerance, physical dependence and naloxone-precipitated withdrawal effects in mice","volume":"3","author":"Shen","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2006.05.005_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.06.003","article-title":"Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in Mu opioid receptor\u2014G protein coupling and G\u03b2\u03b3 signaling","volume":"135","author":"Wang","year":"2005","journal-title":"Neuroscience"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590006007875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590006007875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:43:22Z","timestamp":1761507802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590006007875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1526590006007875"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2006.05.005","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2006.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}